Sg Americas Securities, LLC Replimune Group, Inc. Transaction History

Sg Americas Securities, LLC

$78.3 Billion
Q4 2025

A detailed history of Sg Americas Securities, LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 71,955 shares of REPL stock, worth $646,875. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,955

Previous 98,731 27.12%

Holding current value

$646,875

Previous $414,000 68.84%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 09, 2026	SELL	$4.21 - $10.45 $112,726 - $279,809	-26,776 Reduced 27.12%	71,955 $699,000
Q3 2025 Oct 23, 2025	BUY	$2.81 - $12.63 $248,774 - $1.12 Million	88,532 Added 868.05%	98,731 $414,000
Q2 2025 Aug 08, 2025	SELL	$6.92 - $10.38 $29,057 - $43,585	-4,199 Reduced 29.16%	10,199 $95,000
Q1 2025 Apr 15, 2025	SELL	$9.75 - $14.31 $115,956 - $170,188	-11,893 Reduced 45.24%	14,398 $140,000
Q4 2024 Jan 17, 2025	BUY	$10.54 - $14.93 $35,561 - $50,373	3,374 Added 14.72%	26,291 $318,000

Q3 2024 Oct 03, 2024	BUY	$8.09 - $11.23 $185,398 - $257,357	22,917 New	22,917 $251,000
Q1 2024 May 06, 2024	BUY	$6.87 - $9.31 $123,440 - $167,282	17,968 New	17,968 $147,000
Q1 2023 Apr 28, 2023	SELL	$17.48 - $29.09 $29,908 - $49,772	-1,711 Reduced 12.48%	12,003 $212,000
Q4 2022 Feb 02, 2023	SELL	$17.09 - $27.91 $83,809 - $136,870	-4,904 Reduced 26.34%	13,714 $373,000
Q3 2022 Oct 31, 2022	SELL	$15.6 - $21.15 $210,303 - $285,123	-13,481 Reduced 42.0%	18,618 $322,000
Q2 2022 Jul 29, 2022	SELL	$13.32 - $19.98 $790,941 - $1.19 Million	-59,380 Reduced 64.91%	32,099 $561,000
Q1 2022 Apr 29, 2022	BUY	$15.24 - $29.75 $353,552 - $690,170	23,199 Added 33.98%	91,479 $1.55 Million
Q4 2021 Feb 07, 2022	BUY	$25.43 - $34.25 $1.32 Million - $1.78 Million	52,019 Added 319.9%	68,280 $1.85 Million
Q3 2021 Nov 01, 2021	BUY	$28.98 - $39.54 $393,287 - $536,597	13,571 Added 504.5%	16,261 $482,000
Q2 2021 Aug 12, 2021	SELL	$28.5 - $39.37 $97,812 - $135,117	-3,432 Reduced 56.06%	2,690 $103,000
Q1 2021 May 13, 2021	BUY	$30.22 - $45.57 $44,816 - $67,580	1,483 Added 31.97%	6,122 $187,000
Q4 2020 Feb 04, 2021	BUY	$23.5 - $52.65 $109,016 - $244,243	4,639 New	4,639 $177,000
Q3 2020 Nov 09, 2020	SELL	$18.85 - $27.0 $176,624 - $252,990	-9,370 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$9.76 - $25.95 $91,451 - $243,151	9,370 New	9,370 $233,000

Others Institutions Holding REPL

# of Institutions

192

Shares Held

80.4M

Call Options Held

8.69M

Put Options Held

2.28M

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $443M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Replimune Group, Inc. Transaction History